Efficacy and safety of ruxolitinib in intermediate ‐1 IPSS risk myelofibrosis patients: Results from an independent study
Hematological Oncology,Volume 36, Issue 1, Page 285-290, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - May 17, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 285-290, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - May 17, 2017 Category: Hematology Source Type: research
Comparison of JAK2V617F ‐positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology
Hematological Oncology,Volume 36, Issue 1, Page 269-275, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - May 16, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 269-275, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - May 16, 2017 Category: Hematology Source Type: research
Impact of comorbidity on survival in peripheral T ‐cell lymphomas: A Swedish Lymphoma Registry study
Hematological Oncology,Volume 36, Issue 1, Page 159-165, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - May 5, 2017 Category: Hematology Source Type: research
Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft ‐versus‐host disease and survival outcome
Hematological Oncology,Volume 36, Issue 1, Page 276-284, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - May 5, 2017 Category: Hematology Source Type: research
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib
Hematological Oncology,Volume 36, Issue 1, Page 357-359, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - May 5, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 159-165, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - May 5, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 276-284, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - May 5, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 357-359, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - May 5, 2017 Category: Hematology Source Type: research
Impact of comorbidity on survival in peripheral T ‐cell lymphomas: A Swedish Lymphoma Registry study
Abstract
Comorbidity impacts survival in B‐cell lymphoma patients, but the influence in peripheral T‐cell lymphomas (PTCLs) has been little studied. To investigate the impact of comorbidity on outcome in PTCL, we identified adult patients with newly diagnosed PTCL from 2000 to 2009 in the Swedish Lymphoma Registry. Data on comorbidity at diagnosis were retrospectively collected according to the Charlson Comorbidity Index (CCI). Comorbid conditions were present in 263 out of 694 (38%) patients. A CCI score of ≥2 was associated with inferior overall survival (OS) (hazard ratio [HR] 1.63, P < .001) and progression...
Source: Hematological Oncology - May 5, 2017 Category: Hematology Authors: Fredrik Ellin, Mats Jerkeman, Jenny T örnqvist, Lars Brudin, Thomas Relander Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft ‐versus‐host disease and survival outcome
In conclusion, DPR was a strong predictor of shorter survival but also less frequent chronic GVHD. (Source: Hematological Oncology)
Source: Hematological Oncology - May 5, 2017 Category: Hematology Authors: Yu Akahoshi, Shun ‐ichi Kimura, Ayumi Gomyo, Jin Hayakawa, Masaharu Tamaki, Naonori Harada, Machiko Kusuda, Kazuaki Kameda, Tomotaka Ugai, Hidenori Wada, Yuko Ishihara, Koji Kawamura, Kana Sakamoto, Miki Sato, Kiriko Terasako‐Saito, Misato Kikuchi, Hi Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients
Hematological Oncology,Volume 36, Issue 1, Page 76-83, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 27, 2017 Category: Hematology Source Type: research
The burden of autoimmunity in myelodysplastic syndromes
Hematological Oncology,Volume 36, Issue 1, Page 15-23, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 27, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 76-83, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 27, 2017 Category: Hematology Source Type: research
